'Gamechanger' semaglutide halves diabetes risk from obesity EASD2022
may need to join diabetes prevention as proven effects from obesity intervention before coverage decisions change.that is testing the hypothesis that semaglutide treatment of people with overweight or obesity can reduce the incidence of cardiovascular events in about 17,500 participants and with expected completion toward the end of 2023.
"There is no better tool I know of to predict diabetes incidence," commented Michael A. Nauck, MD, professor and chief of clinical research, diabetes division, St. Josef Hospital in Bochum, Germany. "Our analysis shows that semaglutide treatment is preventing diabetes via several mechanisms. It's not just a reduction in glucose," Garvey said.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Blake Lively’s Photographic Peek at Pregnancy Include Taylor Swift CameoBlake made the post in response to paparazzi following her.
Weiterlesen »
Queen Elizabeth II’s funeral service is Monday. Here’s how to watch.The Washington Post will stream the funeral, as will several major television and radio networks.
Weiterlesen »
Post-Merge Ethereum Hits 2-Month Low, Bitcoin Back Around $18K By Investing.com*ETHEREUM SINKS TO 2-MONTH LOW AS POST-MERGE SLIDE CONTINUES, BITCOIN FALLS TO $18K - BTC BITCOIN ETH
Weiterlesen »